WebOct 1, 2024 · The OPTIMAL study is a randomized, controlled, multicentre, international study. A total of 800 patients will be randomized in a 1:1 fashion to Intravascular Ultrasound (IVUS)-guided PCI versus qualitative angio (QCA)-guided Percutaneous Coronary Intervention (PCI). Patients will be consented prior to the PCI procedure and then followed … WebOptima Health is closely monitoring the spread of the coronavirus (COVID-19). We have enacted our emergency management protocols and our dedicated team continues to …
OPTIMA: Optimal Personalised Treatment of early breast …
WebThe OPTIMA (Optimising the treatment for uncomplicated acute appendicitis) trial is a multicentre, randomised, double-blinded parallel-controlled clinical trial designed to evaluate the therapeutic qualities and efficiency of the combination of antianaerobe strategies compared without use of antianaerobic agents. WebDec 12, 2024 · OPTIMA is a two-arm superiority parallel randomised controlled trial with an internal pilot study. Methods: participants, interventions and outcomes Study setting {9} The trial will be conducted remotely (using phone calls and digital methods), with researchers based in three trial centres: London, Southampton and Nottingham. only the penitent druid solo
OPTIMA trial eligibility - for early breast cancer Cancer Chat
WebJan 24, 2024 · OPTIMA trial eligibility - for early breast cancer 24 Jan 2024 13:12 in response to Embop Hello Embop Just wanted to post to give you this link to information on our website about the OPTIMA trial. You may find it helpful. I'm sorry to hear that the research assistant at your hospital is unavailable to speak to. WebPrevious experience of clinical trials involving an experimental arm in which less treatment is given than is standard clinical practice, such as the ProTect trial, 140 have experienced difficulties in recruitment. 185,186 Prespecified success targets were designed to demonstrate that recruitment into the proposed main trial was feasible once the … WebAug 5, 2024 · The global, randomized, double-blind, placebo-controlled OPTIMA study is evaluated the efficacy of ThermoDox, a lyso-thermosensitive liposomal doxorubicin, in combination with standard RFA for a minimum of 45 minutes for a lesion of 3 to 7 cm in size compared with RFA on its own. only the poets berlin